首页> 美国卫生研究院文献>Cancer Science >Human Tumor Growth Suppression by Apoptosis Induced with Anti‐ErbB‐2 Chimeric Monoclonal Antibody
【2h】

Human Tumor Growth Suppression by Apoptosis Induced with Anti‐ErbB‐2 Chimeric Monoclonal Antibody

机译:抗ErbB-2嵌合单克隆抗体诱导的细胞凋亡抑制人肿瘤生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We established an anti‐ErbB‐2 mouse‐human chimeric monoclonal antibody (MoAb), CH401, which was able to kill cancer cells overexpressing the ErbB‐2 protein in vitro. The analysis of the killing mechanism indicated that MoAb CH401 might be the first anti‐ErbB‐2 mouse‐human chimeric MoAb which can induce the apoptosis of cancer cells, since morphological changes and DNA fragmentation were recognized in MoAb CH401‐treated cells. The ErbB‐2 receptor appears to have two opposing functions: acting as a receptor both for a growth factor and for an apoptotic factor. Our results indicate that MoAb CH401 treatment may prove to be very useful for cancer therapy.
机译:我们建立了抗ErbB-2小鼠人类嵌合单克隆抗体(MoAb)CH401,能够杀死体外过表达ErbB-2蛋白的癌细胞。对杀伤机制的分析表明,MoAb CH401可能是第一个可以诱导癌细胞凋亡的抗ErbB-2小鼠-人类嵌合MoAb,因为在MoAb CH401处理的细胞中可以识别出形态学变化和DNA片段化。 ErbB-2受体似乎具有两个相反的功能:既是生长因子又是凋亡因子的受体。我们的结果表明,MoAb CH401治疗可能被证明对癌症治疗非常有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号